Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.

<h4>Background</h4>A crucial impediment to global tuberculosis control is the lack of an accurate, rapid diagnostic test for detection of patients with active TB. A new, rapid diagnostic method, (Cepheid) Xpert MTB/RIF Assay, is an automated sample preparation and real-time PCR instrumen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Andrea Rachow, Alimuddin Zumla, Norbert Heinrich, Gabriel Rojas-Ponce, Bariki Mtafya, Klaus Reither, Elias N Ntinginya, Justin O'Grady, Jim Huggett, Keertan Dheda, Catharina Boehme, Mark Perkins, Elmar Saathoff, Michael Hoelscher
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/43ac3b52f43c4c9db18b43be74a42869
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:43ac3b52f43c4c9db18b43be74a42869
record_format dspace
spelling oai:doaj.org-article:43ac3b52f43c4c9db18b43be74a428692021-11-18T06:51:03ZRapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.1932-620310.1371/journal.pone.0020458https://doaj.org/article/43ac3b52f43c4c9db18b43be74a428692011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21738575/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>A crucial impediment to global tuberculosis control is the lack of an accurate, rapid diagnostic test for detection of patients with active TB. A new, rapid diagnostic method, (Cepheid) Xpert MTB/RIF Assay, is an automated sample preparation and real-time PCR instrument, which was shown to have good potential as an alternative to current reference standard sputum microscopy and culture.<h4>Methods</h4>We performed a clinical validation study on diagnostic accuracy of the Xpert MTB/RIF Assay in a TB and HIV endemic setting. Sputum samples from 292 consecutively enrolled adults from Mbeya, Tanzania, with suspected TB were subject to analysis by the Xpert MTB/RIF Assay. The diagnostic performance of Xpert MTB/RIF Assay was compared to standard sputum smear microscopy and culture. Confirmed Mycobacterium tuberculosis in a positive culture was used as a reference standard for TB diagnosis.<h4>Results</h4>Xpert MTB/RIF Assay achieved 88.4% (95%CI = 78.4% to 94.9%) sensitivity among patients with a positive culture and 99% (95%CI = 94.7% to 100.0%) specificity in patients who had no TB. HIV status did not affect test performance in 172 HIV-infected patients (58.9% of all participants). Seven additional cases (9.1% of 77) were detected by Xpert MTB/RIF Assay among the group of patients with clinical TB who were culture negative. Within 45 sputum samples which grew non-tuberculous mycobacteria the assay's specificity was 97.8% (95%CI = 88.2% to 99.9%).<h4>Conclusions</h4>The Xpert MTB/RIF Assay is a highly sensitive, specific and rapid method for diagnosing TB which has potential to complement the current reference standard of TB diagnostics and increase its overall sensitivity. Its usefulness in detecting sputum smear and culture negative patients needs further study. Further evaluation in high burden TB and HIV areas under programmatic health care settings to ascertain applicability, cost-effectiveness, robustness and local acceptance are required.Andrea RachowAlimuddin ZumlaNorbert HeinrichGabriel Rojas-PonceBariki MtafyaKlaus ReitherElias N NtinginyaJustin O'GradyJim HuggettKeertan DhedaCatharina BoehmeMark PerkinsElmar SaathoffMichael HoelscherPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 6, p e20458 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Andrea Rachow
Alimuddin Zumla
Norbert Heinrich
Gabriel Rojas-Ponce
Bariki Mtafya
Klaus Reither
Elias N Ntinginya
Justin O'Grady
Jim Huggett
Keertan Dheda
Catharina Boehme
Mark Perkins
Elmar Saathoff
Michael Hoelscher
Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.
description <h4>Background</h4>A crucial impediment to global tuberculosis control is the lack of an accurate, rapid diagnostic test for detection of patients with active TB. A new, rapid diagnostic method, (Cepheid) Xpert MTB/RIF Assay, is an automated sample preparation and real-time PCR instrument, which was shown to have good potential as an alternative to current reference standard sputum microscopy and culture.<h4>Methods</h4>We performed a clinical validation study on diagnostic accuracy of the Xpert MTB/RIF Assay in a TB and HIV endemic setting. Sputum samples from 292 consecutively enrolled adults from Mbeya, Tanzania, with suspected TB were subject to analysis by the Xpert MTB/RIF Assay. The diagnostic performance of Xpert MTB/RIF Assay was compared to standard sputum smear microscopy and culture. Confirmed Mycobacterium tuberculosis in a positive culture was used as a reference standard for TB diagnosis.<h4>Results</h4>Xpert MTB/RIF Assay achieved 88.4% (95%CI = 78.4% to 94.9%) sensitivity among patients with a positive culture and 99% (95%CI = 94.7% to 100.0%) specificity in patients who had no TB. HIV status did not affect test performance in 172 HIV-infected patients (58.9% of all participants). Seven additional cases (9.1% of 77) were detected by Xpert MTB/RIF Assay among the group of patients with clinical TB who were culture negative. Within 45 sputum samples which grew non-tuberculous mycobacteria the assay's specificity was 97.8% (95%CI = 88.2% to 99.9%).<h4>Conclusions</h4>The Xpert MTB/RIF Assay is a highly sensitive, specific and rapid method for diagnosing TB which has potential to complement the current reference standard of TB diagnostics and increase its overall sensitivity. Its usefulness in detecting sputum smear and culture negative patients needs further study. Further evaluation in high burden TB and HIV areas under programmatic health care settings to ascertain applicability, cost-effectiveness, robustness and local acceptance are required.
format article
author Andrea Rachow
Alimuddin Zumla
Norbert Heinrich
Gabriel Rojas-Ponce
Bariki Mtafya
Klaus Reither
Elias N Ntinginya
Justin O'Grady
Jim Huggett
Keertan Dheda
Catharina Boehme
Mark Perkins
Elmar Saathoff
Michael Hoelscher
author_facet Andrea Rachow
Alimuddin Zumla
Norbert Heinrich
Gabriel Rojas-Ponce
Bariki Mtafya
Klaus Reither
Elias N Ntinginya
Justin O'Grady
Jim Huggett
Keertan Dheda
Catharina Boehme
Mark Perkins
Elmar Saathoff
Michael Hoelscher
author_sort Andrea Rachow
title Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.
title_short Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.
title_full Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.
title_fullStr Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.
title_full_unstemmed Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.
title_sort rapid and accurate detection of mycobacterium tuberculosis in sputum samples by cepheid xpert mtb/rif assay--a clinical validation study.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/43ac3b52f43c4c9db18b43be74a42869
work_keys_str_mv AT andrearachow rapidandaccuratedetectionofmycobacteriumtuberculosisinsputumsamplesbycepheidxpertmtbrifassayaclinicalvalidationstudy
AT alimuddinzumla rapidandaccuratedetectionofmycobacteriumtuberculosisinsputumsamplesbycepheidxpertmtbrifassayaclinicalvalidationstudy
AT norbertheinrich rapidandaccuratedetectionofmycobacteriumtuberculosisinsputumsamplesbycepheidxpertmtbrifassayaclinicalvalidationstudy
AT gabrielrojasponce rapidandaccuratedetectionofmycobacteriumtuberculosisinsputumsamplesbycepheidxpertmtbrifassayaclinicalvalidationstudy
AT barikimtafya rapidandaccuratedetectionofmycobacteriumtuberculosisinsputumsamplesbycepheidxpertmtbrifassayaclinicalvalidationstudy
AT klausreither rapidandaccuratedetectionofmycobacteriumtuberculosisinsputumsamplesbycepheidxpertmtbrifassayaclinicalvalidationstudy
AT eliasnntinginya rapidandaccuratedetectionofmycobacteriumtuberculosisinsputumsamplesbycepheidxpertmtbrifassayaclinicalvalidationstudy
AT justinogrady rapidandaccuratedetectionofmycobacteriumtuberculosisinsputumsamplesbycepheidxpertmtbrifassayaclinicalvalidationstudy
AT jimhuggett rapidandaccuratedetectionofmycobacteriumtuberculosisinsputumsamplesbycepheidxpertmtbrifassayaclinicalvalidationstudy
AT keertandheda rapidandaccuratedetectionofmycobacteriumtuberculosisinsputumsamplesbycepheidxpertmtbrifassayaclinicalvalidationstudy
AT catharinaboehme rapidandaccuratedetectionofmycobacteriumtuberculosisinsputumsamplesbycepheidxpertmtbrifassayaclinicalvalidationstudy
AT markperkins rapidandaccuratedetectionofmycobacteriumtuberculosisinsputumsamplesbycepheidxpertmtbrifassayaclinicalvalidationstudy
AT elmarsaathoff rapidandaccuratedetectionofmycobacteriumtuberculosisinsputumsamplesbycepheidxpertmtbrifassayaclinicalvalidationstudy
AT michaelhoelscher rapidandaccuratedetectionofmycobacteriumtuberculosisinsputumsamplesbycepheidxpertmtbrifassayaclinicalvalidationstudy
_version_ 1718424289024147456